Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

The Effectiveness of Low-Dose Decitabine Following Infusion of Autologous Hematopoietic Stem Cells in Patients Experiencing Persistent Pancytopenia after CD19-CART

Xutao Guo, Yunxia Zhang, Haohao Lei, Yongqiang Wei, Xiaolei Wei, Qi Wei, Ru Feng

Blood (2024) 144 (Supplement 1): 7249.

https://doi.org/10.1182/blood-2024-201948

Published: 2024

Journal Articles

Optimizing Time-Limited Therapy in Unfit CLL/SLL Patients: Orelabrutinib, Bendamustine, and Obinutuzumab Combination (OBG) Regimen

Xutao Guo, Xiaolei Wei, Yongqiang Wei, Qi Wei, Ning Su, Yunxia Zhang, Haohao Lei, Ru Feng

Blood (2024) 144 (Supplement 1): 6776.

https://doi.org/10.1182/blood-2024-207666

Published: 2024

Journal Articles

Sintilimab, Rituximab and Lenalidomide (sR2) As First-Line Treatment in Elderly Patients with Diffuse Large B-Cell Lymphoma: A Single-Arm, Open-Label, Phase 2 Trial

Xiaolei Wei, Xutao Guo, Qi Wei, Yongqiang Wei, Ru Feng

Blood (2024) 144 (Supplement 1): 3121.

https://doi.org/10.1182/blood-2024-204940

Published: 2024

Journal Articles

The Addition of Lenalidomide to R-CHOP Is Effective for Prevention of CNS Relapse in High-Risk Patients with Diffuse Large B-Cell Lymphoma

Xiaolei Wei, Xutao Guo, Qi Wei, Dan Xiong, Peng Zhang, Zewen Zhang, Yongqiang Wei, Ru Feng

Blood (2024) 144 (Supplement 1): 1740.

https://doi.org/10.1182/blood-2024-204915

Published: 2024

Journal Articles

RHOA G17V Mutation Exhibits Markedly Different Functions in the Presence of TET2 Loss in T-Cells

Anurag Kumar, Qi Wei, Ruimeng Yang, Xuxiang Liu, Jibin Zhang, Alyssa Bouska, Javeed Iqbal, Wing Chung Chan

Blood (2024) 144 (Supplement 1): 1360.

https://doi.org/10.1182/blood-2024-211029

Published: 2024

Journal Articles

The Addition of Lenalidomide to R-CHOP Is Effective for Prevention of CNS Relapse in High-Risk Patients with Diffuse Large B-Cell Lymphoma

Xiaolei Wei, Xutao Guo, Qi Wei, Dan Xiong, Peng Zhang, Zewen Zhang, Yongqiang Wei, Ru Feng

Blood (2023) 142 (Supplement 1): 6223.

https://doi.org/10.1182/blood-2023-182496

Published: 2023

Journal Articles

The Prognostic Value of Dynamic Change of NK-Cell Counts in Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Chen Huan, Zhongxin Zheng, Yongqiang Wei, Xutao Guo, Qi Wei, Ru Feng, Xiaolei Wei

Blood (2023) 142 (Supplement 1): 6262.

https://doi.org/10.1182/blood-2023-181412

Published: 2023

Journal Articles

DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS

Blood (2022) 140 (11): 1278–1290.

https://doi.org/10.1182/blood.2021015019

Published: 2022

Includes: Supplemental data

Journal Articles

The Efficacy of Plerixafor Plus Recombinant Human Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients with Lymphoma and Plasma Cell Diseases

Xutao Guo, Yongqiang Wei, Xiaolei Wei, Haiqing Zheng, Yunxia Zhang, Haohao Lei, Qi Wei, Qifa Liu, Ru Feng

Blood (2021) 138 (Supplement 1): 4851.

https://doi.org/10.1182/blood-2021-148487

Published: 2021

Journal Articles

Consecutive Hypoalbuminemia Predicts Inferior Outcome in Patients with Diffuse Large B-Cell Lymphoma

Xiaolei Wei, Jingxia Zheng, Zewen Zhang, Qiongzhi Liu, Minglang Zhan, Weimin Huang, Jianbo Liu, Qi Wei, Yongqiang Wei, Ru Feng

Blood (2020) 136 (Supplement 1): 31.

https://doi.org/10.1182/blood-2020-139534

Published: 2020

Journal Articles

Levels of N-Terminal Pro-B-Type Natriuretic Peptide Relate to Risk of Infection in Multiple Myeloma Patients

Weimin Huang, Xiaolei Wei, Qi Wei, Yongqiang Wei, Ru Feng

Blood (2020) 136 (Supplement 1): 31.

https://doi.org/10.1182/blood-2020-139067

Published: 2020

Journal Articles

PKM2 Expression Is Associated with Favorable Outcome in Patients with Diffuse Large B-Cell Lymphoma

Yongqiang Wei, MD, Xiaolei Wei, Jialin Song, Weimin Huang, Hong Zeng, Jingxia Zheng, Qi Wei, Ru Feng, MD

Blood (2018) 132 (Supplement 1): 5319.

https://doi.org/10.1182/blood-2018-99-112849

Published: 2018

Journal Articles

Albumin Improves Stratification in the Low IPI Risk Patients with Diffuse Large B-Cell Lymphoma

Xiaolei Wei, Yongqiang Wei, MD, Weimin Huang, Jialin Song, Hong Zeng, Jingxia Zheng, Qi Wei, Ru Feng, MD

Blood (2018) 132 (Supplement 1): 5412.

https://doi.org/10.1182/blood-2018-99-112824

Published: 2018

Journal Articles

Varicella Zoster Virus Reactivation Can be Prevented Very Well By Valacyclovir in Patients with Multiple Myeloma Treated with Bortezomib

Qi Wei, Yongqiang Wei, MD, Ru Feng, MD, Xiaolei Wei

Blood (2018) 132 (Supplement 1): 5655.

https://doi.org/10.1182/blood-2018-99-113369

Published: 2018

Journal Articles

Sequential Azacitidine (Aza) and Lenalidomide (Len) for Patients (Pts) with Relapsed and Refractory (R/R) Acute Myeloid Leukemia (AML): Clinical Results and Predictive Modeling Using Computational Analysis and Serial Genomics

Brett M. Stevens, PhD, Amanda Winters, MD PhD, Jonathan A Gutman, MD, Aaron Fullerton, BS, Gregory Hemenway, MS2, Nicholas Miltgen, BS, Qi Wei, MD, Taher Abbasi, MS, MBA, Shireen Vali, PhD, Neeraj Kumar Singh, B.Tech, Leylah M. Drusbosky, PhD, Chris R. Cogle, MD, Andrew Hammes, MS, Craig T. Jordan, PhD, Daniel A. Pollyea, MD

Blood (2017) 130 (Supplement 1): 1337.

https://doi.org/10.1182/blood.V130.Suppl_1.1337.1337

Published: 2017

Journal Articles

A Story about a Mother with Chronic Lymphocytic Leukemia after Chronic Phase of Chronic Myeloid Leukemia and Her Daughter with Chronic Myeloid Leukemia: Case Report and Literature Review

Qi Wei, MD, Yongqiang Wei, MD, Xiaolei Wei, Xiaofang LI, MD, Hui Liu, MD, Ru Feng, MD

Blood (2017) 130 (Supplement 1): 5265.

https://doi.org/10.1182/blood.V130.Suppl_1.5265.5265

Published: 2017

Journal Articles

Beta-2 Microglobulin Improves the IPI Risk Stratification in Patients with Diffuse Large B-Cell Lymphoma

Yongqiang Wei, MD, Xiaolei Wei, Weimin Huang, Jialin Song, Qi Wei, MD, Ru Feng, MD

Blood (2017) 130 (Supplement 1): 5233.

https://doi.org/10.1182/blood.V130.Suppl_1.5233.5233

Published: 2017

Journal Articles

Low Serum Albumin Predicts Inferior Outcome in Patients with Diffuse Large B-Cell Lymphoma

Xiaolei Wei, Yongqiang Wei, MD, Weimin Huang, Jialin Song, Qi Wei, MD, Ru Feng, MD

Blood (2017) 130 (Supplement 1): 5237.

https://doi.org/10.1182/blood.V130.Suppl_1.5237.5237

Published: 2017

Journal Articles

CD44 over Expression Caused Drug Resistance in Activated B Cell-like Diffuse Large B-Cell Lymphoma

Qinjun Zhou, Yongqiang Wei, Xiaolei Wei, Qi Wei, Ru Feng

Blood (2016) 128 (22): 5316.

https://doi.org/10.1182/blood.V128.22.5316.5316

Published: 2016

Journal Articles

Influence of Biological Character of Acute Lymphoblastic Leukemia Cell Linet after Overexpression of C/EBPa and PU.1

Linwei Xu, Xiaoxiao Hao, Yongqiang Wei, Xiaolei Wei, Qi Wei, Ru Feng, MD

Blood (2016) 128 (22): 5060.

https://doi.org/10.1182/blood.V128.22.5060.5060

Published: 2016

NARROW

The Effectiveness of Low-Dose Decitabine Following Infusion of Autologous Hematopoietic Stem Cells in Patients Experiencing Persistent Pancytopenia after CD19-CART

Optimizing Time-Limited Therapy in Unfit CLL/SLL Patients: Orelabrutinib, Bendamustine, and Obinutuzumab Combination (OBG) Regimen

Sintilimab, Rituximab and Lenalidomide (sR2) As First-Line Treatment in Elderly Patients with Diffuse Large B-Cell Lymphoma: A Single-Arm, Open-Label, Phase 2 Trial

The Addition of Lenalidomide to R-CHOP Is Effective for Prevention of CNS Relapse in High-Risk Patients with Diffuse Large B-Cell Lymphoma

RHOA G17V Mutation Exhibits Markedly Different Functions in the Presence of TET2 Loss in T-Cells

The Addition of Lenalidomide to R-CHOP Is Effective for Prevention of CNS Relapse in High-Risk Patients with Diffuse Large B-Cell Lymphoma

The Prognostic Value of Dynamic Change of NK-Cell Counts in Diffuse Large B-Cell Lymphoma Treated with R-CHOP

DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS

The Efficacy of Plerixafor Plus Recombinant Human Granulocyte Colony-Stimulating Factor for Autologous Stem-Cell Mobilization and Transplantation for Patients with Lymphoma and Plasma Cell Diseases

Consecutive Hypoalbuminemia Predicts Inferior Outcome in Patients with Diffuse Large B-Cell Lymphoma

Levels of N-Terminal Pro-B-Type Natriuretic Peptide Relate to Risk of Infection in Multiple Myeloma Patients

PKM2 Expression Is Associated with Favorable Outcome in Patients with Diffuse Large B-Cell Lymphoma

Albumin Improves Stratification in the Low IPI Risk Patients with Diffuse Large B-Cell Lymphoma

Varicella Zoster Virus Reactivation Can be Prevented Very Well By Valacyclovir in Patients with Multiple Myeloma Treated with Bortezomib

Sequential Azacitidine (Aza) and Lenalidomide (Len) for Patients (Pts) with Relapsed and Refractory (R/R) Acute Myeloid Leukemia (AML): Clinical Results and Predictive Modeling Using Computational Analysis and Serial Genomics

A Story about a Mother with Chronic Lymphocytic Leukemia after Chronic Phase of Chronic Myeloid Leukemia and Her Daughter with Chronic Myeloid Leukemia: Case Report and Literature Review

Beta-2 Microglobulin Improves the IPI Risk Stratification in Patients with Diffuse Large B-Cell Lymphoma

Low Serum Albumin Predicts Inferior Outcome in Patients with Diffuse Large B-Cell Lymphoma

CD44 over Expression Caused Drug Resistance in Activated B Cell-like Diffuse Large B-Cell Lymphoma

Influence of Biological Character of Acute Lymphoblastic Leukemia Cell Linet after Overexpression of C/EBPa and PU.1

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only